SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-06-000096
Filing Date
2006-02-09
Accepted
2006-02-09 16:30:53
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a17152e10vq.htm 10-Q 369171
2 EXHIBIT 10.1 a17152exv10w1.htm EX-10.1 112219
3 EXHIBIT 15.1 a17152exv15w1.htm EX-15.1 2879
4 EXHIBIT 31.1 a17152exv31w1.htm EX-31.1 6858
5 EXHIBIT 31.2 a17152exv31w2.htm EX-31.2 6891
6 EXHIBIT 32.1 a17152exv32w1.htm EX-32.1 2533
7 EXHIBIT 32.2 a17152exv32w2.htm EX-32.2 2567
8 GRAPHIC a17152a1715201.gif GRAPHIC 12400
  Complete submission text file 0000936392-06-000096.txt   521894
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 06593442
SIC: 2834 Pharmaceutical Preparations